Patient Guide: A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 57 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06691113
Status: 🟢 Enrolling Now
Condition: Chronic Rhinosinusitis Without Nasal Polyps
Phase: PHASE2

Where You Can Participate

This study is available at 57 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • La Jolla, California
  • • Murrieta, California
  • • And 54 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps - Join Clinical Trial NCTNCT06691113

How to Join This Clinical Trial - NCTNCT06691113

Learn how to participate in this PHASE2 trial studying an investigational therapy for Chronic Rhinosinusitis Without Nasal Polyps. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Rhinosinusitis Without Nasal Polyps. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Rhinosinusitis Without Nasal Polyps
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06691113 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 57 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35209 - United States

Status: RECRUITING

Clinical Research Site

La Jolla, California 92037 - United States

Status: RECRUITING

Clinical Research Site

Murrieta, California 92563 - United States

Status: RECRUITING

Clinical Research Site

Roseville, California 95661 - United States

Status: RECRUITING

Clinical Research Site

Wheat Ridge, Colorado 80033 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33176 - United States

Status: RECRUITING

Clinical Research Site

Boise, Idaho 83706 - United States

Status: RECRUITING

Clinical Research Site

McKinney, Texas 75070 - United States

Status: RECRUITING

Clinical Research Site

San Antonio, Texas 78258 - United States

Status: RECRUITING

Clinical Research Site

Norfolk, Virginia 23507 - United States

Status: RECRUITING

And 47 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Chronic Rhinosinusitis Without Nasal Polyps:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships